跳至主要内容
临床试验/NCT04842123
NCT04842123已完成不适用

Electrocardiogram Clinical Validation Study

Garmin International6 个研究点 分布在 1 个国家目标入组 568 人开始时间: 2021年3月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
568
试验地点
6
主要终点
Specificity of rhythm classification

研究概览

简要总结

The purpose of the study is to confirm the Garmin ECG (electrocardiogram) software algorithm can detect and classify atrial fibrillation and normal sinus rhythm on single lead ECG data derived from a Garmin wrist-worn, consumer device. The study will also confirm the software's ability to create a Lead I ECG that is clinically equivalent to a reference device. The Garmin ECG software is not a diagnostic system and is intended for informational purposes only.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Able to read, understand, and provide written informed consent;
  • •Willing and able to participate in the study procedures as described in the consent form;
  • •Individuals who are 22 years of age and older;
  • •Able to communicate effectively with and follow instructions from the study staff;
  • •Have a wrist circumference that fits within the device band; and
  • •For subjects enrolled into the AF population, subjects must have a known diagnosis of AF and be in AF at the time of screening.

排除标准

  • •Physical disability that precludes safe and adequate testing;
  • •Mental impairment resulting in limited ability to cooperate;
  • •Subjects with a pacemaker or implantable cardioverter-defibrillator (ICD);
  • •Acute myocardial infarction within 90 days of screening or other cardiovascular disease that, in the opinion of the Investigator, increases the risk to the subject or renders data uninterpretable;
  • •Acute pulmonary embolism, pulmonary infarction, or deep vein thrombosis within 90 days of screening;
  • •Stroke or transient ischemic attack within 90 days of screening;
  • •Subjects taking rhythm control drugs;
  • •Symptomatic (or active) allergic skin reactions such as eczema, rosacea, impetigo, dermatomyositis, or allergic contact dermatitis on both wrists or over electrode attachment sites, including known allergy or sensitivity to silicone bands primarily used in wrist-worn fitness devices;
  • •Known sensitivity to medical adhesives, isopropyl alcohol, watch bands, or ECG electrodes;
  • •A history of abnormal life-threatening rhythms as determined by the Investigator;
  • •Significant tremor that prevents subject from being able to hold still;
  • •Women who are pregnant at the time of study participation; and
  • •Subjects enrolled into the SR population must not have any diagnosis of AF.

研究组 & 干预措施

Atrial fibrillation (AF)

Other

Patients with a known history of AF who are in AF at the time of study screening.

干预措施: Electrocardiogram (Diagnostic Test)

Normal Sinus Rhythm (SR)

Other

Patients with no known diagnosis of AF or other arrhythmia

干预措施: Electrocardiogram (Diagnostic Test)

结局指标

主要结局

Specificity of rhythm classification

时间窗: 1 Day

Number of participants with a SR software rhythm classification in agreement with a physician's interpretation of heart rhythm based on gold standard 12-lead ECG

Sensitivity of rhythm classification

时间窗: 1 Day

Number of participants with an AF software rhythm classification in agreement with a physician's interpretation of heart rhythm based on gold standard 12-lead ECG

次要结局

  • Number of ECGs that pass a visual overlay(Day 1)
  • Difference in R-wave amplitudes between the software and gold standard reference(Day 1)

研究者

发起方
Garmin International
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验